Data as of Dec 17
| +1.05 / +1.91%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 65.00, with a high estimate of 65.00 and a low estimate of 58.00. The median estimate represents a +15.80% increase from the last price of 56.13.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.